Effectiveness of the Myofascial Therapy in the Hemophilic Arthropathy of Ankle
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02825667|
Recruitment Status : Completed
First Posted : July 7, 2016
Last Update Posted : September 28, 2017
Randomized clinical trial to assess the efficacy of a treatment protocol applied fascial therapy in patients with hemophilic arthropathy ankle, oriented to know and describe the observed differences on the dependent variables: range of motion, pain and physical condition.
At the same time, the study will determine whether there are adverse effects or bleeding complications as a result of applied physiotherapy treatment.
|Condition or disease||Intervention/treatment||Phase|
|Haemophilia||Other: Physiotherapy sessions||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||65 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Randomized Clinical Study on the Effectiveness of the Myofascial Therapy in the Treatment of the Hemophilic Arthropathy of Ankle|
|Actual Study Start Date :||September 12, 2016|
|Actual Primary Completion Date :||September 8, 2017|
|Actual Study Completion Date :||September 26, 2017|
Experimental: Experimental group
Patients included in this group will receive treatment over a period of three weeks, receiving 3 physiotherapy sessions lasting approximately 30 minutes each.
The treatment program includes 8 maneuvers that must be administered bilaterally: maneuver longitudinal sliding on the fascial surface plant, maneuver induction of the plantar fascia, maneuver longitudinal surface sliding on the anterolateral compartment of the leg, induction maneuver ankle anterior compartment, maneuver pressure and sliding on the posterior region of the leg, technical release of the popliteal fascia, maneuver induction sural triceps, and lower extremity telescopic technique.
Other: Physiotherapy sessions
Physiotherapy by techniques myofascial therapy, in patients with ankle hemophilic arthropathy
No Intervention: Control group
Patients included in this group will not receive any physiotherapy treatment. However, will be evaluated under the same conditions that patients in the experimental group (pretreatment evaluation, post-treatment and follow-up).
- Change from baseline bleeding frequency after treatment and at 5 months [ Time Frame: Screening visit, within the first seven days after treatment and after five months follow-up visit ]Evaluation of the frequency of muscle and joint bleeds through registration. The frequency of bleeding of the ankle joint is measured with a registry given to patients at the beginning of the study.
- Change from baseline joint pain of ankle after treatment and at 5 months [ Time Frame: Screening visit, within the first seven days after treatment and after five months follow-up visit ]Change from joint pain of ankle during treatment and follow-up period at 5 months. The perception of ankle pain will be measured using visual analog scale (scale 0-10).
- Change from baseline joint function after treatment and at 5 months [ Time Frame: Screening visit, within the first seven days after treatment and after five months follow-up visit ]Change from joint health during treatment and follow-up period at 5 months. Measurement instrument: Haemophilia Joint Health Score (scale 0-20).
- Change from baseline range of motion after treatment and at 5 months [ Time Frame: Screening visit, within the first seven days after treatment and after five months follow-up visit ]
Change from range of movement of ankle and knee during treatment and follow-up period at 5 months. The range of motion of the ankle joint will be measured using a universal goniometer, using the protocol for measuring joint motion described by Felipe Querol.
Measurement instrument: universal goniometer with the protocol to measurement for patients with hemophilia
- Age [ Time Frame: Screening visit ]Age of patients
- Weight [ Time Frame: Screening visit ]Weight of patients included in the study
- Height [ Time Frame: Screening visit ]Height of patients
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02825667
|Principal Investigator:||Rubén Cuesta-Barriuso, PhD||Real Fundación Victoria Eugenia|